Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Bisaro Insider Profile
4 Followers
Paul Bisaro, EC, Director at Amneal Pharmaceuticals, holds 40.15K shares in Myriad Genetics (Ticker: MYGN), holds 21.78K shares in Zoetis (Ticker: ZTS), holds 32.05K shares in Mallinckrodt public limited company (Ticker: MNKTQ).
Paul Bisaro Amneal Pharmaceuticals (AMRX)EC, Director
Amneal Pharmaceuticals (AMRX)
EC, Director
Ranked #88,587 out of 98,042 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-54.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Paul Bisaro holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul Bisaro
Paul Bisaro's Trading History
Amneal Pharmaceuticals
May 09, 2019
EC, Director
Uninformative Buy
167.38K
$219.43K
Allergan
Mar 06, 2018
―
Uninformative Sell
434.44K
$73.80M
TherapeuticsMD
Aug 22, 2022
Director
Uninformative Buy
20.28K
$10.54K
Myriad Genetics
Jun 07, 2024
Director
Uninformative Buy
―
$1.11M
Mallinckrodt public limited company
Jun 29, 2023
―
Uninformative Sell
4.72K
$3.85K
Zimmer Biomet Holdings
―
Director
―
$0.00
Zoetis
Feb 13, 2024
Director
Uninformative Buy
288.68K
$3.94M
List of latest transactions for each holding click on a transaction to see Paul Bisaro's performance on stock
You May Also Like
Paul Bisaro insider profile FAQ
What is the percentage of profitable transactions made by Paul Bisaro?
The percentage of profitable transactions made by Paul Bisaro is 0%.
What is the average return per transaction made by Paul Bisaro?
The average return per transaction made by Paul Bisaro is -54.80%.
What stocks does Paul Bisaro hold?
Paul Bisaro holds: AMRX, AGN, TXMD, MYGN, MNKTQ, ZBH, ZTS stocks.
What was Paul Bisaro’s latest transaction?
Paul Bisaro latest transaction was an Uninformative Buy of ―.
What was Paul Bisaro's most profitable transaction?
Paul Bisaro’s most profitable transaction was an Informative Buy of TXMD stock on June 8, 2020. The return on the trade was -16.10%.
What is Paul Bisaro's role in Amneal Pharmaceuticals?
Paul Bisaro's role in Amneal Pharmaceuticals is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.